1. 2022-RA-629-ESGO Association of folate receptor α expression and tumor immune microenvironment in patients with cervical cancer. (20th October 2022) Authors: Yazaki, Shu; Chiba, Yohei; Kojima, Yuki; Yoshida, Hiroshi; Takamizawa, Shigemasa; Kitadai, Rui; Saito, Ayumi; Okuma, Hitomi Suimyoshi; Nishikawa, Tadaaki; Shimoi, Tatsunori; Sudo, Kazuki; Noguchi, Emi; Uno, Masaya; Ishikawa, Misuya; Kato, Tomoyasu; Furuuchi, Keiji; Uenaka, Toshimitsu; Fujiwara, Y... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-793-ESGO TROP-2 expression and the tumor immune-microenvironment in cervical cancer. (20th October 2022) Authors: Chiba, Yohei; Yazaki, Shu; Kojima, Yuki; Yoshida, Hiroshi; Takamizawa, Shigemasa; Kitadai, Rui; Saito, Ayumi; Okuma, Hitomi Sumiyoshi; Nishikawa, Tadaaki; Shimoi, Tatsunori; Sudo, Kazuki; Noguchi, Emi; Uno, Masaya; Ishikawa, Mitsuya; Kato, Tomoyasu; Fujiwara, Yasuhiro; Yonemori, Kan Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non–small cell lung cancer: A real-world multicentre study. (January 2021) Authors: Desilets, Antoine; Blanc-Durand, Félix; Lau, Sally; Hakozaki, Taiki; Kitadai, Rui; Malo, Julie; Belkaid, Wiam; Richard, Corentin; Messaoudene, Meriem; Cvetkovic, Lena; Kazandjian, Suzanne; Tehfe, Mustapha; Florescu, Marie; Jao, Kevin; Daaboul, Nathalie; Owen, Scott; Shieh, Benjamin; Agulnik, Jaso... Journal: European journal of cancer Issue: Volume 142(2021) Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Switching administration of anti‐PD‐1 and anti‐PD‐L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non‐small cell lung cancer: Case series and literature review. Issue 7 (18th May 2020) Authors: Kitagawa, Shingo; Hakozaki, Taiki; Kitadai, Rui; Hosomi, Yukio Journal: Thoracic cancer Issue: Volume 11:Issue 7(2020) Page Start: 1927 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Development of drugs targeting hypoxia‐inducible factor against tumor cells with VHL mutation: Story of 127 years. Issue 4 (31st January 2023) Authors: Takamori, Hajime; Yamasaki, Toshinari; Kitadai, Rui; Minamishima, Yoji Andrew; Nakamura, Eijiro Journal: Cancer science Issue: Volume 114:Issue 4(2023) Page Start: 1208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Intracranial complete response for non‐small‐cell lung cancer patient with negative PD‐L1 expression of the lung using nivolumab. Issue 2 (27th May 2021) Authors: Kitadai, Rui; Zenke, Yoshitaka; Hishima, Tsunekazu; Hosomi, Yukio Journal: Cancer reports Issue: Volume 5:Issue 2(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗